SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma inks pact to acquire Women Health Rx Portfolio of BSV

13 Oct 2025 Evaluate

Mankind Pharma has executed a Business Transfer Agreement (BTA) with its wholly owned subsidiary -- Bharat Serums and Vaccines (BSV), for acquisition of BSV’s Branded Generic Business relating to Women Health Rx Portfolio on going concern basis by way of slump sale. The company will acquire the business at a consideration of Rs 797 crore. The 50% of the sale consideration shall be paid on the Closing Date as defined in the BTA, while balance sale consideration shall be payable within 150 days from the Closing Date.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Share Price

2078.75 24.65 (1.20%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×